Avid Bioservices, Inc. (CDMO)

Avid Bioservices Income Statement

Financials in millions USD. Fiscal year is May - April.

Year	2024	2023	2022	2021	2020
Revenue	139.91	149.27	119.6	95.87	59.7
Revenue Growth (YoY)	-6.27%	24.81%	24.75%	60.58%	11.38%
Cost of Revenue	132.59	117.79	82.95	66.56	55.77
Gross Profit	7.32	31.48	36.65	29.31	3.93
Selling, General & Admin	26	27.88	21.23	17.06	14.52
Other Operating Expenses	0	0	0	0	0.36
Operating Expenses	26	27.88	21.23	17.06	14.87
Operating Income	-18.68	3.6	15.42	12.24	-10.94
Interest Expense / Income	4.34	3.01	2.68	1.16	0.01
Other Expense / Income	3.91	-1	0.08	-0.13	-0.48
Pretax Income	-26.93	1.59	12.66	11.21	-10.47
Income Tax	113.83	1.33	-115.01	0	0
Net Income	-140.75	0.26	127.67	11.21	-10.47
Preferred Dividends	0	0	0	7.89	4.69
Net Income Common	-140.75	0.26	127.67	3.32	-15.15
Net Income Growth	-	-99.80%	3747.86%	-	-
Shares Outstanding (Basic)	63	62	61	58	56
Shares Outstanding (Diluted)	63	64	70	59	56
Shares Change	-0.91%	-9.50%	18.59%	5.50%	0.62%
EPS (Basic)	-2.23	-	2.08	0.06	-0.27
EPS (Diluted)	-2.23	-	1.84	0.06	-0.27
EPS Growth	-	-	2966.67%	-	-
Free Cash Flow	-20.85	-90.53	-46.95	21.32	2.02
Free Cash Flow Per Share	-0.33	-1.45	-0.76	0.37	0.04
Gross Margin	5.23%	21.09%	30.64%	30.57%	6.59%
Operating Margin	-13.35%	2.41%	12.89%	12.77%	-18.32%
Profit Margin	-100.60%	0.17%	106.75%	3.46%	-25.38%
Free Cash Flow Margin	-14.90%	-60.65%	-39.25%	22.24%	3.38%
Effective Tax Rate	-	83.71%	-908.39%	-	-
EBITDA	-11.48	11.81	19.82	15.83	-7.37
EBITDA Margin	-8.21%	7.91%	16.57%	16.51%	-12.34%
Depreciation & Amortization	11.11	7.21	4.48	3.45	3.09
EBIT	-22.59	4.6	15.34	12.38	-10.46
EBIT Margin	-16.15%	3.08%	12.83%	12.91%	-17.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).